leadf
logo-loader
CSE:INNO

InnoCan Pharma

Receive alerts
Market:
CSE
Market Cap:
$47.44 m
Price
0.27 CAD
Change
-1.82%
52 weeks high
0.35
52 weeks low
0.05

Innocan Pharma™ was established in October 2017, following years of intensive research and analysis into medical cannabis activity in Israel and its potential to contribute to the global pharmaceutical industry.

The Innocan Pharma™ Team enjoys the capabilities of leading Israeli pharmaceutical industry executives, including Ron Mayron, former CEO of Teva Israel, Yoram Druker Co-founder Pluristem, Brainstorm and Cell Source Ltd, Iris Bincovich developing global business strategies ( Kamedis, Efal), and Nir Avram VP R&D at Careline and was previously  a member of the pharmaceutical innovation team at Perrigo. Innoca Pharma™ believes that by merging pharma, science, and the therapeutic benefits of Cannabinoids, it is possible to create a truly effective over the counter topical treatments product line.

Innocan Pharma™ is also working to develop pharmaceutical new field related to cannabinoids such as the new platform to facilitate the targeted controlled administration of cannabinoids (such as CBD) via injection (INNOVATION).

PRODUCTS

Innocan Pharma brings proprietary pharmaceutical knowledge and experience combined with technological innovation to deliver the new generation of cannabis- integrated pharmaceuticals

 

Skincare Collection

 

OTC Collection

 

 

RON MAYRON

Executive Chairman

Extensive global experience in the pharmaceutical industry. Managerial positions at Teva Pharmaceutical for more than 20 years, as CEO Israel & Africa, VP Commercial International group, VP Russia and Eastern Europe countries.

IRIS BINCOVICH

CEO

Track record in developing global business strategies to open and penetrate new markets. Managed successful international transactions from senior management positions (Kamedis, Efal). Guided startups from early stage to commercialization (Tagra).

YORAM DRUCKER

Founder & VP Business Development

Successful Israeli entrepreneur and expert in the establishment of successful start-ups. Co-founded Pluristem (NASDAQ: PSTI), Brainstorm (NASDAQ: BCLI) and Cell Source Ltd (CLCS.OB).

NIR AVRAM

BSC, MSC CTO

Senior pharmaceutics scientist with more than 30 years’ experience. Serves as VP R&D at Careline and was a member of the pharmaceutical innovation team at Perrigo. He holds several patents on OTC applications.

NELSON HALPERN

FCPA, FCA, TEP CFO

Extensive experience as CFO for public and private companies. Member of the Chartered Professional Accountants of Alberta. Received a Distinguished Service Award from the Chartered Professional Accountants of Alberta in 2005 and received an “FCA” designation as a Fellow Chartered accountant in 2013 for his contribution to his community and the profession.

Email - [email protected]